Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis. King AC, Derkach A, Weis TM, Stump SE, et al. Leuk Res 2022;122:106929.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

King AC, Derkach A, Weis TM, Stump SE, et al. Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis. Leuk Res 2022;122:106929.
PMID: 36244178